揚科集團(01460.HK)中期純利跌74%至2107.6萬港元
格隆匯11月28日丨揚科集團(01460.HK)公佈,截至2019年9月30日止6個月,實現收益3.31億港元,同比增長36.74%;毛利5407.3萬港元,同比增長37.27%;純利2107.6萬港元,同比減少74.00%;每股盈利0.44港仙。
公告稱,有關減少主要歸因於以下各項的淨影響:毛利較2018年中期增加約1470萬港元;與2018年中期相比,可換股債券衍生部分公平值變動及轉換可換股債券的收益合共減少約3130萬港元;與2018年中期相比,應付或然代價公平值變動減少約2400萬港元;及與2018年中期相比,由於薪資增加集團一般及行政開支增加約1660萬港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.